4.4 Article

EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway

Journal

JOURNAL OF GENERAL VIROLOGY
Volume 89, Issue -, Pages 1563-1568

Publisher

MICROBIOLOGY SOC
DOI: 10.1099/vir.0.2008/001461-0

Keywords

-

Funding

  1. NCI NIH HHS [R01 CA062234, R01 CA133063, R01 CA073507-12, CA73507, R01 CA133063-01A1, CA62234, R01 CA073507] Funding Source: Medline
  2. NIAID NIH HHS [R01 AI067048, AI067048, T32 AI060523] Funding Source: Medline

Ask authors/readers for more resources

Latent membrane protein 2A (LMP2A) of Epstein-Barr virus (EBV) provides developmental and survival signals that mimic those of a B-cell receptor (BCR). Expression of LMP2A during B-cell development results in the ability of B cells to exit the bone marrow in the absence of a BCR and persist in the periphery, where they would normally undergo apoptosis. This study extends the current knowledge of LMP2A function by examining the growth properties of bone marrow B cells from TgE LMP2A mice. Despite the lack of pre-BCR expression, bone marrow B cells from TgE LMP2A mice proliferate and survive in low concentrations of interleukin 7, similar to wild-type cells. Constitutive phosphorylation of ERK/MAPK and PI3K/Akt in TgE LMP2A bone marrow B cells is also reminiscent of signalling through the pre-BCR, altogether demonstrating that LMP2A provides a pre-BCR-like signal to developing B cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available